Chinese regulators have greenlit the first wave of Nvidia's advanced H200 AI chip orders for major firms including Alibaba and ByteDance, marking a potential turning point for the chipmaker's access to a critical market and fueling optimism for its stock trajectory.
Amazon's ongoing corporate restructuring has resulted in significant layoffs across its Seattle-area headquarters, with software engineers among the most affected roles, as the tech giant continues to streamline operations and invest in AI.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
While Boise Cascade's five-year total shareholder return of 110% has significantly outperformed its modest earnings growth, the building materials firm's recent stock slump raises questions about its valuation and future trajectory in a volatile market.
Despite lagging the S&P 500 over the past year, DoorDash retains overwhelming 'Strong Buy' ratings from analysts who see significant upside potential, even after a volatile post-earnings sell-off.
In a strategic move to cut costs and bolster infrastructure, Telia Norway and Lyse-owned Ice are merging their mobile radio access networks into a new joint venture, aiming to build a nationwide challenger to market leader Telenor.
Micron Technology shares surged again Monday, fueled by a new analyst report highlighting strong demand for its high-bandwidth memory chips and forecasting a significant rise in DRAM prices through 2026.
A powerful but uncommon shift in market leadership is underway as small-caps, energy, and value stocks drive gains. While a sign of health, historical parallels to similar 'breadth' events often coincided with economic stress.
Amid market volatility driven by AI speculation, a seasoned investor makes the case for a dual-anchor strategy built on Apple's surging iPhone sales and Berkshire Hathaway's formidable $378 billion cash reserve.
ARK Invest's Cathie Wood has made a significant $10 million purchase of Joby Aviation shares, signaling continued conviction in the eVTOL pioneer despite recent stock volatility and a critical year ahead for FAA certification and commercialization.
Despite a strong year of performance and record annual revenue, analyst sentiment toward Morgan Stanley stock reflects a blend of confidence and caution as the financial giant navigates a complex economic landscape.
A 64-year-old man has been sentenced to life without parole after pleading guilty to murdering his estranged wife and her aunt during a domestic dispute that escalated from a trivial disagreement.
New research reveals a stark disconnect: while a majority of firms are ramping up investment in incentive pay to fuel growth, widespread execution errors are rendering these costly programs ineffective, leaving potential revenue on the table.
Nvidia's journey from a niche graphics card maker to the world's most valuable company is a masterclass in technological foresight and market adaptation. This is how a bet on parallel processing powered the AI revolution.
An analysis of the most-held stocks on the Robinhood platform reveals where the retail investing crowd is placing its bets, with two tech giants emerging as particularly compelling long-term investments.
Fosun International's stock has tumbled over 14% in the last 90 days, reigniting the debate over the Chinese conglomerate's true worth. With shares trading at HK$4.12 against a widely cited fair value of HK$5.77, analysts are divided on whether this is a moment of market overreaction or a sign of deeper structural challenges.
Broadcom (AVGO) shares present a complex picture for investors, with recent pullbacks contrasting sharply with stellar multi-year gains. As the chip giant navigates its AI-driven growth story, analysts debate whether the current price still offers value or if risks are mounting.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
